1. Bojanic I, Mahnik A, Jelic M, Josipovic M, Smoljanovic T. Ligament which deserves attention-medial patellofemoral ligament. Lijec Vjesn. 2012;134(7-8):224–32.
2. Popovac H, Bojanic I, Smoljanovic T. Leg length discrepancy as a rare cause of a piriformis syndrome. J Back Musculoskelet Rehabil. 2012;25(4):299–300.
3. Smoljanovic T, Bogovic M, Bojanic I. Bone morphogenetic protein. J Neurosurg Spine. 2012;17(1):98–9.
4. Dimnjakovic D, Bojanic I, Smoljanovic T, Mahnik A, Barbaric-Peraic N. Eccentric exercises in the treatment of overuse injuries of the musculoskeletal system. Lijec Vjesn. 2012;134(1-2):29–41.
5. Bojanic I, Smoljanovic T, Dokuzovic S. Osteochondritis dissecans of the elbow: excellent results in teenage athletes treated by arthroscopic debridement and microfracture. Croat Med J. 2012;53(1):40–7.
6. Pecina M, Bojanic I, Smoljanovic T, Ivkovic A, Mirkovic M, Jelic M. Surgical treatment of diaphyseal stress fractures of the fifth metatarsal in competitive athletes: long-term follow-up and computerized pedobarographic analysis. J Am Podiatr Med Assoc. 2011;101(6):517–22.
7. Bojanic I, Rogosic S, Mahnik A, Smoljanovic T. Removal of osteoid osteoma of the tibia using two-portal posterior ankle arthroscopy. J Foot Ankle Surg. 2012;51(1):103–5.
8. Delimar D, Smoljanovic T, Bojanic I. Could the use of bone morphogenetic proteins in fracture healing do more harm than good to our patients? Int Orthop. 2012;36(3):683–5.
9. Smoljanovic T, Bojanic I, Pollock CL, Radonic R. Rib stress fracture in a male adaptive rower from the arms and shoulders sport class: case report. Croat Med J. 2011;52(5):644–7.
10. Kubat O, Mahnik A, Smoljanovic T, Bojanic I. Arthroscopic treatment of localized and diffuse pigmented villonodular synovitis of the knee. Coll Antropol. 2010;34(4):1467–72.
11. Rakovac M, Bojanic I, Smoljanovic T. Recombinant human bone morphogenetic protein 2 labeled use in spinal surgery and sexual dysfunction. Surg Neurol Int. 2011;2:55.
12. Rakovac M, Smoljanovic T, Bojanic I, Hannafin JA, Hren D, Thomas P. Body size changes in elite junior rowers: 1997 to 2007. Coll Antropol. 2011;35(1):127–31.
13. Bojanic I, Smoljanovic T, Kubat O. Osteochondritis dissecans of the first metatarsophalangeal joint: arthroscopy and microfracture technique. J Foot Ankle Surg. 2011;50(5):623–5.
14. Smoljanovic T, Bojanic I. An evolving perception of the risk of rhBMP-2 use for anterior spinal interbody fusions. Spine J. 2011;11(6):520–1.
15. Smoljanovic T, Bojanic I, Pecina M. Sciatic nerve division: anatomic support for clinical work. Singapore Med J. 2011;52(4):319.
16. Rogosic S, Bojanic I, Boric I, Tudor A, Srdoc D, Sestan B. Unrecognized fracture of the posteromedial process of the talus--a case report and review of literature. Acta Clin Croat. 2010;49(3):315–20.
17. Smoljanovic T, Rakovac M, Bojanic I. Could chronic host inflammatory response be responsible for delayed onset of retrograde ejaculation after the labeled use of recombinant human bone morphogenetic protein-2? Spine J. 2011;11(2):167–8.
18. Smoljanovic T, Josipovic M, Bojanic I. The justification for recombinant human bone morphogenetic protein-2 use in one- or two-level lumbar spine interbody fusions. J Clin Neurosci. 2011;18(3):445–6.
19. Pećina M, Bojanić I, Ivković A, Brčić L, Smoljanović T, Seiwerth S. Patellar tendinopathy: histopathological examination and follow-up of surgical treatment. Acta Chir Orthop Traumatol Cech. 2010;77(4):277-83.
20. Smoljanovic T, Siric F, Bojanic I. Six-year outcomes of anterior lumbar interbody arthrodesis with use of interbody fusion cages and recombinant human bone morphogenetic protein-2. J Bone Joint Surg Am. 2010;92(15):2614–5.
21. Bojanic I, Smoljanovic T, Mahnik A. Arthroscopy of the elbow. Lijec Vjesn. 2010;132(7-8):238–45.
22. Smoljanovic T, Bicanic G, Bojanic I. Re: Kleeman TJ, Ahn UM, Talbot-Kleeman A. Laparoscopic anterior lumbar interbody fusion with rhBMP-2: a prospective study of clinical and radiographic outcomes. Spine 2001;26:2751-6. Spine (Phila Pa 1976). 2010;35(20):E1013.
23. Smoljanovic T, Bojanic I. Re: Mroz TE, Wang JC, Hashimoto R, et al. Complications related to osteobiologics use in spine surgery: a systematic review. Spine (Phila Pa 1976) 2010;35:S86-104. Spine (Phila Pa 1976). 2010;35(20):E1010.
24. Smoljanovic T, Bojanic I, Cimic M. Re: Boden SD, Zdeblick TA, Sandhu HS, et al. The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine. 2000; 25:376-81. Spine (Phila Pa 1976). 2010;35(20):E1010–1011.
25. Smoljanovic T, Dokuzovic S, Bojanic I. Osteoinductive bone graft substitutes for lumbar fusion. J Neurosurg Spine. 2010;13(3):407–9.
26. Smoljanovic T, Caric D, Bojanic I. RE: Clinical applications of bone morphogenetic proteins: current evidence. Kanakaris, NK; Giannoudis, PV; JSOA 17(3):133-46, 2008. J Surg Orthop Adv. 2010;19(2):135–7.
27. Smoljanovic T, Bojanic I, Rakovac M. Re: Sasso RC, Burkus JK, LeHuec JC. Retrograde ejaculation after anterior lumbar interbody fusion: transperitoneal versus retroperitoneal exposure. Spine (Phila Pa 1976) 2003;28:1023-6. Spine (Phila Pa 1976). 2010;35(14):E622
28. Bojanic I, Vuletic LB, Troha I, Smoljanovic T, Boric I, Seiwerth S. Synovial chondromatosis. Lijec Vjesn. 2010;132(3-4):102–10.
29. Smoljanovic T, Aljinovic A, Bojanic I. Recommendation for use of rhBMP-2 in spinal interbody fusions. Eur Spine J. 2010;19(8):1385–6
30. Smoljanovic T, Stipcic I, Bojanic I. The level of evidence in clinical studies of the use of rhBMP-2 in spinal interbody fusions. Eur Spine J. 2010;19(8):1387–8.
31. Smoljanovic T, Bicanic G, Bojanic I. Update of comprehensive review of the safety profile of bone morphogenetic protein in spine surgery. Neurosurgery. 2010;66(5):E1030.
32. Smoljanovic T, Bojanic I, Dokuzovic S. Re: Mindea SA, Shih P, Song JK. Recombinant human bone morphogenetic protein-2-induced radiculitis in elective minimally invasive transforaminal lumbar interbody fusions: a series review. Spine 2009;34:1480-5. Spine (Phila Pa 1976). 2010;35(8):929.
33. Cerovecki T, Bojanic I, Brcic L, Radic B, Vukoja I, Seiwerth S, et al. Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat. J Orthop Res. 2010;28(9):1155–61.
34. Smoljanovic T, Cimic M, Bojanic I. Is a barrier really necessary to prevent radiculitis when using recombinant human bone morphogenetic protein-2 in proximity of nerve roots? Spine J. 2010;10(3):279.
35. Pevec D, Novinscak T, Brcic L, Sipos K, Jukic I, Staresinic M, et al. Impact of pentadecapeptide BPC 157 on muscle healing impaired by systemic corticosteroid application. Med Sci Monit. 2010;16(3):BR81–8.
36. Smoljanovic T, Bojanic I, Bicanic G, Delimar D. Re: Toth JM, Boden SD, Burkus JK, et al. Short-term osteoclastic activity induced by locally high concentrations of recombinant human bone morphogenetic protein-2 in a cancellous bone environment. Spine 2009;34:539-50. Spine (Phila Pa 1976). 2010;35(5):597.
37. Smoljanovic T, Cimic M, Bojanic I. Aggressive end plate decortication as a cause of osteolysis after rhBMP-2 use in cervical spine interbody fusion. Spine J. 2010;10(2):187–8.
38. Smoljanovic T, Bojanic I, Vlahovic Z. Safety of posterior interbody fusions of the lumbar spine using rhBMP-2. J Spinal Disord Tech. 2010;23(1):78.
39. Cimic M, Smoljanovic T, Bojanic I. Re: Hiremath GK, Steinmetz MP, Krishnaney AA. Is it safe to use recombinant human bone morphogenetic protein in posterior cervical fusion? Spine 2009;34:885-9. Spine (Phila Pa 1976). 2010;35(3):361.
40. Smoljanovic T, Smigovec I, Bojanic I. Funding source and clinical trial outcome. Am J Orthop (Belle Mead NJ). 2009;38(11):540–0.
41. Smoljanovic T, Siric F, Bojanic I. Complications associated with use of bone-morphogenetic proteins in spinal fusion procedures. JAMA. 2009;302(19):2090–1.
42. Bojanic I, Bergovec M, Smoljanovic T. Combined anterior and posterior arthroscopic portals for loose body removal and synovectomy for synovial chondromatosis. Foot Ankle Int. 2009;30(11):1120–3.
43. Smoljanovic T, Janjanin S, Bojanic I. Avoiding unanticipated adverse effects of recombinant human bone morphogenetic protein-2 therapy in craniofacial surgery with experiences from spinal applications. J Craniofac Surg. 2009;20(5):1626.
44. Smoljanovic T, Bojanic I, Pecina M. The use of bone morphogenetic protein in lumbar spine surgery. J Bone Joint Surg Am. 2009;91(8):2045–6.
45. Mikulic P, Smoljanovic T, Bojanic I, Hannafin JA, Matkovic BR. Relationship between 2000-m rowing ergometer performance times and World Rowing Championships rankings in elite-standard rowers. J Sports Sci. 2009;27(9):907–13.
46. Smoljanovic T, Bojanic I, Cimic M. Bone morphogenetic protein. J Neurosurg Spine. 2009;11(1):92–3.
47. Smoljanovic T, Bojanic I, Pecina M. End plates resorptions after the applications of rhBMP-2 for interbody spinal fusions. J Spinal Disord Tech. 2009;22(4):309–10.
48. Smoljanovic T, Bojanic I, Delimar D. Adverse effects of posterior lumbar interbody fusion using rhBMP-2. Eur Spine J. 2009;18(6):920–3.
49. Smoljanovic T, Bojanic I, Hannafin JA, Hren D, Delimar D, Pecina M. Traumatic and overuse injuries among international elite junior rowers. Am J Sports Med. 2009;37(6):1193–9.
50. Smoljanovic T, Bojanic I, Dapic T. Significance of early CT evaluation after lumbar interbody fusions using recombinant human bone morphogenetic protein-2. AJNR Am J Neuroradiol. 2009;30(5):e71.
51. Mikulic P, Smoljanovic T, Bojanic I, Hannafin J, Pedisic Z. Does 2000-m rowing ergometer performance time correlate with final rankings at the World Junior Rowing Championship? A case study of 398 elite junior rowers. J Sports Sci. 2009;27(4):361–6.
52. Smoljanovic T, Bojanic I, Pecina M. The confusion of important literature review. Spine J. 2009;9(5):427–8.
|